Dechang Diao
Clinical trials sponsored by Dechang Diao, explained in plain language.
-
Sparing lymph nodes during radiation may boost immune attack on rectal cancer
Disease control Recruiting nowThis phase 2 trial compares two treatment plans for people with locally advanced rectal cancer that is mismatch repair proficient (pMMR) or microsatellite stable (MSS). One group receives standard short-course radiation followed by chemotherapy. The other group receives a newer a…
Phase: PHASE2 • Sponsor: Dechang Diao • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Immunotherapy combo shows promise in Hard-to-Treat rectal cancer
Disease control Recruiting nowThis phase 2 trial tests whether adding an immunotherapy drug (PD-1 antibody) and a blood vessel blocker (bevacizumab) to standard short-course radiotherapy and chemotherapy can improve outcomes for people with a common type of locally advanced rectal cancer (pMMR/MSS). About 86 …
Phase: PHASE2 • Sponsor: Dechang Diao • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC